F552 in Montana. Pick another state for the same tag.
Against expectation — 2025
Montana cites F552 more often than its own record predicts
Versus expected share1.45×
1.45 times the share F552 takes of citations nationally.
Share of Montana citations0.78%
Of every deficiency written in Montana in 2025, this is the portion that was F552.
Montana0.78%
National0.54%
Share of all citations that were F552.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Montana surveyors wrote
F552 findings written in Montana, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 13, 2026
Based on interview and record review, the facility failed to ensure that a resident and/or the resident's representative was made aware of the risks and benefits associated with the use of antipsychotic and psychotropic medication before the start of treatment for 1 (#35) of 5 residents sampled for unnecessary medication. Findings include:During an interview on 8/12/26 at 3:20 p.m., with staff members D and F, staff member D stated that medication consents for antipsychotic and psychotropic medications were obtained during the first care plan conference after a resident was admitted to the facility. Staff member D stated resident #35 was admitted to the facility on [DATE] and had not had his initial care plan conference. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction